REFERENCES
- Bort R., Ponsoda X., Carrasco E., Gomez-Lechon M. J., Castell J. V. Metabolism of aceclofenac in humans. Drug Metab. Dispos. 1996; 24: 834–841, [INFOTRIEVE], [CSA]
- Brogden R. N., Wiseman L. R. Aceclofenac: a review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management. Drugs 1996; 52: 113–124, [INFOTRIEVE], [CSA]
- Committee for Proprietary Medicinal Products (CPMP). Note for Guidance: Investigation of Bioavailability and Bioequivalence. Informa UK Ltd, London 1991
- El Kousy N. M. Spectrophotometric and spectrofluorimetric determination of etodolac and aceclofenac. J. Pharm. Biomed. Anal. 1999; 20: 185–194, [INFOTRIEVE], [CSA], [CROSSREF]
- Farolfi M., Power J. D., Rescigno A. On the determination of bioequivalence. Pharmacol. Res. 1999; 39: 1–4, [INFOTRIEVE], [CSA], [CROSSREF]
- Hanses A., Saphn-Langguth H., Mutschler E. A new rapid and sensitive high performance liquid chromatographic assay for diclofenac in human plasma. Archiv der Pharmazie 1995; 328: 257–260, [INFOTRIEVE], [CSA], [CROSSREF]
- Hasan N. Y., Abdel-Elkawy M., Elzeany B. E., Wagieh N. E. Stability indicating methods for the determination of aceclofenac. Farmaco 2003; 58: 91–99, [INFOTRIEVE], [CSA], [CROSSREF]
- Hauschke D., Steinijans V. W., Diletti E. A distribution free procedure for the statistical analysis of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 1990; 28: 72–78, [INFOTRIEVE], [CSA]
- Hinz B., Auge D., Rau T., Rietbrock S., Brune K., Werner U. Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography. Biomed. Chromatogr. 2003; 17: 268–275, [INFOTRIEVE], [CSA], [CROSSREF]
- Lansdrop D., Janssen T. J., Guelen P. J. M., Vree T. B. High performance liquid chromatographic method for the determination of diclofenac and its hydroxy metabolites in human plasma and urine. J. Chromatogr. 1990; 528: 487–494, [CSA]
- Lee H. S., Jeong C. K., Choi S. J., Kim S. B., Lee M. H., Ko G. I., Sohn D. H. Simultaneous determination of aceclofenac and diclofenac in human plasma by narrowbore HPLC using column-switching. J. Pharm. Biomed. Anal. 2000; 23: 775–781, [INFOTRIEVE], [CSA], [CROSSREF]
- Legrand E. Aceclofenac in the management of inflammatory pain. Expert Opin. Pharmacother. 2004; 5: 1347–1357, [INFOTRIEVE], [CSA], [CROSSREF]
- Najib N., Idkaidek N., Beshtawi M., Bader M., Admour I., Alam S., Zaman Q., Dham R. Bioequivalence evaluation of two brands of aceclofenac 100 mg tablets (Aceclofar and Bristaflam) in healthy human volunteers. Biopharm. Drug. Dispos. 2004; 25: 103–108, [INFOTRIEVE], [CSA], [CROSSREF]
- Nation R. L, Sansom L. N. Bioequivalence requirements for generic products. Pharmacol. Ther. 1994; 62: 41–55, [INFOTRIEVE], [CSA], [CROSSREF]
- Schulz H. U., Steinijans V. W. Striving for standards in bioequivalence assessment: a review. Int. J. Clin. Pharmacol. Ther. Toxicol. 1992; 30: S1–S6, [INFOTRIEVE], [CSA]
- Shah V. P., Midha K. K., Sighe S. Analytical method validation: bioavailability, bioequivalence and pharmacokinetic studies. Eur. J. Drug Metab. Pharmacokin. 1992; 16: 249–255, [CSA]
- U.S. Food and Drug Administration. Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products—General Considerations. Informa UK Ltd, Rockville, MD 2000
- Zawilla N. H., Mohammad M. A., El Kousy N. M., El-Moghazy Aly S. M. Determination of aceclofenac in bulk and pharmaceutical formulations. J. Pharm. Biomed. Anal. 2002; 27: 243–251, [INFOTRIEVE], [CSA], [CROSSREF]